Kidney in primary aldosteronism: A key determinant of treatment outcome
暂无分享,去创建一个
[1] Yen-Hung Lin,et al. Primary aldosteronism: changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment , 2011, Journal of hypertension.
[2] Y. Komiyama,et al. The central mechanism underlying hypertension: a review of the roles of sodium ions, epithelial sodium channels, the renin–angiotensin–aldosterone system, oxidative stress and endogenous digitalis in the brain , 2011, Hypertension Research.
[3] Yen-Hung Lin,et al. Kidney impairment in primary aldosteronism. , 2011, Clinica chimica acta; international journal of clinical chemistry.
[4] D. Lyn,et al. Eplerenone suppresses aldosterone/ salt-induced expression of NOX-4 , 2011, Journal of the renin-angiotensin-aldosterone system : JRAAS.
[5] C. Catena,et al. Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment. , 2010, American journal of hypertension.
[6] L. Sechi,et al. The dual role of the kidney in primary aldosteronism: key determinant in rescue from volume expansion and persistence of hypertension. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[7] Yen-Hung Lin,et al. Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[8] M. Bazzocchi,et al. Intrarenal hemodynamics in primary aldosteronism before and after treatment. , 2009, The Journal of clinical endocrinology and metabolism.
[9] R. Holle,et al. Risk factors associated with a low glomerular filtration rate in primary aldosteronism. , 2009, The Journal of clinical endocrinology and metabolism.
[10] W. Young,et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. , 2008, The Journal of clinical endocrinology and metabolism.
[11] E. Letavernier,et al. Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma , 2008, Journal of hypertension.
[12] C. Yabe-Nishimura,et al. Synergy of aldosterone and high salt induces vascular smooth muscle hypertrophy through up-regulation of NOX1 , 2008, The Journal of Steroid Biochemistry and Molecular Biology.
[13] P. Strazzullo,et al. Primary aldosteronism: cardiovascular, renal and metabolic implications , 2008, Trends in Endocrinology & Metabolism.
[14] H. Matsubara,et al. Aldosterone Nongenomically Produces NADPH Oxidase–Dependent Reactive Oxygen Species and Induces Myocyte Apoptosis , 2008, Hypertension Research.
[15] J. Funder. Mineralocorticoid receptor activation and oxidative stress. , 2007, Hypertension.
[16] L. Sechi,et al. Long-Term Cardiac Effects of Adrenalectomy or Mineralocorticoid Antagonists in Patients With Primary Aldosteronism , 2007, Hypertension.
[17] L. Sechi,et al. Relationships of plasma renin levels with renal function in patients with primary aldosteronism. , 2007, Clinical journal of the American Society of Nephrology : CJASN.
[18] W. Young. Primary aldosteronism: renaissance of a syndrome , 2007, Clinical endocrinology.
[19] E. Porteri,et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. , 2006, Journal of the American College of Cardiology.
[20] R. Patni,et al. Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes. , 2006, Clinical journal of the American Society of Nephrology : CJASN.
[21] D. Rizzoni,et al. Renal Damage in Primary Aldosteronism: Results of the PAPY Study , 2006, Hypertension.
[22] M. Novello,et al. Long-term renal outcomes in patients with primary aldosteronism. , 2006, JAMA.
[23] M. Ermani,et al. Long-Term Results of Adrenalectomy in Patients with Aldosterone-Producing Adenomas: Multivariate Analysis of Factors Affecting Unresolved Hypertension and Review of the Literature , 2005, The American surgeon.
[24] S. Bianchi,et al. Antagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot study. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[25] N. Brown. Aldosterone and end-organ damage , 2005, Clinical science.
[26] P. Fesler,et al. Relative glomerular hyperfiltration in primary aldosteronism. , 2005, Journal of the American Society of Nephrology : JASN.
[27] M. Boscaro,et al. Aldosterone as a cardiovascular risk factor , 2005, Trends in Endocrinology & Metabolism.
[28] N. Hollenberg. Aldosterone in the development and progression of renal injury. , 2004, Kidney international.
[29] J. Funder. Is aldosterone bad for the heart? , 2004, Trends in Endocrinology & Metabolism.
[30] G. Chatellier,et al. Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[31] W. Young,et al. Increased Diagnosis of Primary Aldosteronism, Including Surgically Correctable Forms, in Centers from Five Continents , 2004 .
[32] M. Stowasser,et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after ‘non-selective’ screening of hypertensive patients , 2003, Journal of hypertension.
[33] E. Blasi,et al. Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. , 2003, Kidney international.
[34] T. Inenaga,et al. Cause of residual hypertension after adrenalectomy in patients with primary aldosteronism. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[35] T. Fujii,et al. Cardiovascular complications in patients with primary aldosteronism. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[36] D. Huglo,et al. Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism? , 1998, Surgery.
[37] J. Funder,et al. Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: in vivo binding studies. , 1996, Endocrinology.
[38] C. Lo,et al. Primary Aldosteronism: Results of Surgical Treatment , 1996 .
[39] J. Melby,et al. Factors influencing outcome of surgery for primary aldosteronism. , 1996, Archives of surgery.
[40] J. Laragh,et al. Diagnosis and Treatment of Primary Hyperaldosteronism , 1994, Annals of Internal Medicine.
[41] M. Stowasser,et al. RESPONSE TO UNILATERAL ADRENALECTOMY FOR ALDOSTERONE‐PRODUCING ADENOMA: EFFECT OF POTASSIUM LEVELS AND ANGIOTENSIN RESPONSIVENESS , 1994, Clinical and experimental pharmacology & physiology.
[42] Y. Fujimoto,et al. Risk factors associated with postoperative persistent hypertension in patients with primary aldosteronism. , 1992, Surgery.
[43] Y. Kawano,et al. Renal function curve in patients with secondary forms of hypertension. , 1987, Hypertension.
[44] B. Brenner,et al. Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension. , 1984, The Journal of clinical investigation.
[45] N. Javadpour,et al. Renal changes in primary aldosteronism. , 1977, Journal of Urology.
[46] J. Brown,et al. Renal abnormalities and vascular complications in primary hyperaldosteronism. Evidence on tertiary hyperaldosteronism. , 1976, The Quarterly journal of medicine.
[47] J. Laragh. Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. , 1973, The American journal of medicine.
[48] C. Stier,et al. Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats. , 1998, Hypertension.
[49] J. Conn,et al. CLINICAL CHARACTERISTICS OF PRIMARY ALDOSTERONISM FROM AN ANALYSIS OF 145 CASES. , 1964, American journal of surgery.